CADTH,
School of Engineering,University of Warwick.
Int J Technol Assess Health Care. 2018 Jan;34(3):276-289. doi: 10.1017/S0266462318000314. Epub 2018 Jun 18.
Current health technology assessment (HTA) methods guidelines for medical devices may benefit from contributions by biomedical and clinical engineers. Our study aims to: (i) review and identify gaps in the current HTA guidelines on medical devices, (ii) propose recommendations to optimize the impact of HTA for medical devices, and (iii) reach a consensus among biomedical engineers on these recommendations.
A gray literature search of HTA agency Web sites for assessment methods guidelines on devices was conducted. The International Federation of Medical and Biological Engineers (IFMBE) then convened a structured focus group, with experts from different fields, to identify potential gaps in the current HTA guidelines, and to develop recommendations to fill these perceived gaps. The thirty recommendations generated from the focus group were circulated in a Delphi survey to eighty-five biomedical and clinical engineers.
Thirty-two panelists, from seventeen countries, participated in the Delphi survey. The responses showed a strong agreement on twenty-seven of thirty recommendations. Some uncertainties remain about the methods to accurately assess the effectiveness and safety, and interoperability of a medical device with other devices or within the clinical setting.
As medical devices differ from drug therapies, current HTA methods may not accurately reflect the conclusions of their assessment. Recommendations informed by the focus group discussions and Delphi survey responses aimed to address the perceived gaps, and to provide a more integrated approach in medical device assessments in combining engineering with other perspectives, such as clinical, economic, patient, human factors, ethical, and environmental.
医疗器械现行的健康技术评估(HTA)方法指南可能需要生物医学和临床工程师的贡献。本研究旨在:(i)审查和确定医疗器械现行 HTA 指南中的差距,(ii)提出优化医疗器械 HTA 影响的建议,以及(iii)在这些建议上达成生物医学工程师的共识。
对 HTA 机构网站上的医疗器械评估方法指南进行了灰色文献检索。然后,国际医学和生物工程联合会(IFMBE)召集了一个由不同领域专家组成的结构化焦点小组,以确定当前 HTA 指南中的潜在差距,并提出填补这些感知差距的建议。焦点小组提出的三十条建议在一项德尔菲调查中向八十五名生物医学和临床工程师进行了分发。
来自十七个国家的三十二名小组成员参加了德尔菲调查。调查结果表明,对三十条建议中的二十七条有强烈的共识。对于如何准确评估医疗器械与其他设备或在临床环境中的有效性和安全性以及互操作性,仍存在一些不确定性。
由于医疗器械与药物疗法不同,当前的 HTA 方法可能无法准确反映其评估结论。根据焦点小组讨论和德尔菲调查的回应提出的建议旨在解决感知到的差距,并提供更具整体性的医疗器械评估方法,即将工程学与其他视角(如临床、经济、患者、人为因素、伦理和环境)相结合。